Rallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
— 100 mg Results Demonstrated a Mean Reduction of Greater than 93% in Free C5 with Low Volume Once-a-Week Subcutaneous Dosing — — Data Supports... Read more.
Construction Starts Hit 10-Month Low, Declining 15% in November
Nonresidential starts lead decline, dropping 29% HAMILTON, N.J.–(BUSINESS WIRE)–Total construction starts fell 15% in November, dropping to a seasonally... Read more.
SunOpta Inc. to Participate in Upcoming Investor Conference
MINNEAPOLIS–(BUSINESS WIRE)–SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a U.S.-based global pioneer fueling the future... Read more.
Payoneer Introduces New Product Features to Propel Small Business Growth
Product enhancements help SMBs around the world increase payment efficiency and add greater flexibility and control. NEW YORK–(BUSINESS WIRE)–Payoneer... Read more.
Oscar Health, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference
NEW YORK–(BUSINESS WIRE)–Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Executive... Read more.
Marti Announces Expiration and Results of the Offer to Purchase and Consent Solicitation Relating to its Warrants and Issues Notice of Redemption with Respect to its Outstanding Warrants
ISTANBUL–(BUSINESS WIRE)–Marti Technologies, Inc. (“Marti” or the “Company”) (NYSE American: MRT), Türkiye’s leading mobility app, today announced... Read more.
Global Cardiopulmonary Oxygenator Market Set to Reach $926 Million by 2028, Driven by Aging Populations and Technological Advances – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Cardiopulmonary Oxygenator Market: Analysis By Product Type (Membrane Oxygenator and Bubble Oxygenator), By... Read more.
Arrowhead Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to present at the upcoming... Read more.
Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024
LEXINGTON, Mass.–(BUSINESS WIRE)–Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat... Read more.
New Chief Financial Officer Appointed
Continued Exploration Success Opens New Drilling Opportunities and Plays in the Llanos Basin BOGOTA, Colombia–(BUSINESS WIRE)–GeoPark Limited (“GeoPark”... Read more.